146 related articles for article (PubMed ID: 24333336)
1. Resveratrol suppresses prostaglandin F(2α)-induced osteoprotegerin synthesis in osteoblasts: inhibition of the MAP kinase signaling.
Kuroyanagi G; Tokuda H; Matsushima-Nishiwaki R; Kondo A; Mizutani J; Kozawa O; Otsuka T
Arch Biochem Biophys; 2014 Jan; 542():39-45. PubMed ID: 24333336
[TBL] [Abstract][Full Text] [Related]
2. Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts.
Kuroyanagi G; Mizutani J; Kondo A; Yamamoto N; Matsushima-Nishiwaki R; Otsuka T; Kozawa O; Tokuda H
Prostaglandins Leukot Essent Fatty Acids; 2014 Sep; 91(3):73-80. PubMed ID: 24813642
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase.
Yamamoto N; Otsuka T; Kuroyanagi G; Kondo A; Kainuma S; Nakakami A; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Prostaglandins Other Lipid Mediat; 2015; 116-117():57-63. PubMed ID: 25677506
[TBL] [Abstract][Full Text] [Related]
4. Regulation by resveratrol of prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts.
Yamamoto N; Tokuda H; Kuroyanagi G; Mizutani J; Matsushima-Nishiwaki R; Kondo A; Kozawa O; Otsuka T
Int J Mol Med; 2014 Nov; 34(5):1439-45. PubMed ID: 25234201
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation by resveratrol of basic fibroblast growth factor-stimulated osteoprotegerin synthesis through suppression of Akt in osteoblasts.
Kuroyanagi G; Otsuka T; Yamamoto N; Matsushima-Nishiwaki R; Nakakami A; Mizutani J; Kozawa O; Tokuda H
Int J Mol Sci; 2014 Oct; 15(10):17886-900. PubMed ID: 25290095
[TBL] [Abstract][Full Text] [Related]
6. Incretins Enhance PGF2α-Induced Synthesis of IL-6 and Osteoprotegerin in Osteoblasts.
Hioki T; Kuroyanagi G; Fujita K; Sakai G; Kawabata T; Kim W; Tachi J; Matsushima-Nishiwaki R; Iida H; Kozawa O; Tokuda H
Horm Metab Res; 2022 Jan; 54(1):42-49. PubMed ID: 34986499
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol Inhibits the Epidermal Growth Factor-Induced Migration of Osteoblasts: the Suppression of SAPK/JNK and Akt.
Kawabata T; Tokuda H; Fujita K; Kainuma S; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
Cell Physiol Biochem; 2017; 43(3):1025-1036. PubMed ID: 28968596
[TBL] [Abstract][Full Text] [Related]
8. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
[TBL] [Abstract][Full Text] [Related]
9. Acetaminophen reduces osteoprotegerin synthesis stimulated by PGE
Kim W; Tokuda H; Tanabe K; Yamaguchi S; Hioki T; Tachi J; Matsushima-Nishiwaki R; Kozawa O; Iida H
Biomed Res; 2021; 42(2):77-84. PubMed ID: 33840687
[TBL] [Abstract][Full Text] [Related]
10. Mimosine suppresses the PGF2α-induced synthesis of osteoprotegerin but not interleukin-6 in osteoblasts.
Kuroyanagi G; Otsuka T; Yamamoto N; Kainuma S; Ohguchi R; Fujita K; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Int J Mol Med; 2016 Feb; 37(2):533-41. PubMed ID: 26744072
[TBL] [Abstract][Full Text] [Related]
11. Amplification by (‑)‑epigallocatechin gallate of prostaglandin F2α‑stimulated synthesis of osteoprotegerin in osteoblasts.
Sakai G; Otsuka T; Fujita K; Kainuma S; Kuroyanagi G; Kawabata T; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Mol Med Rep; 2017 Nov; 16(5):6376-6381. PubMed ID: 28849144
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol amplifies BMP-4-stimulated osteoprotegerin synthesis via p38 MAP kinase in osteoblasts.
Kuroyanagi G; Tokuda H; Yamamoto N; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Otsuka T
Mol Med Rep; 2015 Sep; 12(3):3849-3854. PubMed ID: 26044505
[TBL] [Abstract][Full Text] [Related]
13. Tramadol enhances PGF
Kim W; Tanabe K; Kuroyanagi G; Matsushima-Nishiwaki R; Fujita K; Kawabata T; Sakai G; Tachi J; Hioki T; Nakashima D; Yamaguchi S; Otsuka T; Tokuda H; Kozawa O; Iida H
Heliyon; 2020 Aug; 6(8):e04779. PubMed ID: 32904295
[TBL] [Abstract][Full Text] [Related]
14. Tiludronate inhibits prostaglandin F2alpha-induced vascular endothelial growth factor synthesis in osteoblasts.
Yoshida M; Tokuda H; Ishisaki A; Kanno Y; Harada A; Shimuzu K; Kozawa O
Mol Cell Endocrinol; 2005 May; 236(1-2):59-66. PubMed ID: 15922088
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Rho-kinase in prostaglandin F2alpha-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts.
Minamitani C; Otsuka T; Takai S; Matsushima-Nishiwaki R; Adachi S; Hanai Y; Mizutani J; Tokuda H; Kozawa O
Mol Cell Endocrinol; 2008 Sep; 291(1-2):27-32. PubMed ID: 18586382
[TBL] [Abstract][Full Text] [Related]
16. AMP-activated protein kinase inhibitor decreases prostaglandin F2α-stimulated interleukin-6 synthesis through p38 MAP kinase in osteoblasts.
Kondo A; Otsuka T; Kato K; Natsume H; Kuroyanagi G; Mizutani J; Ito Y; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Int J Mol Med; 2012 Dec; 30(6):1487-92. PubMed ID: 23064268
[TBL] [Abstract][Full Text] [Related]
17. Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts.
Kainuma S; Otsuka T; Kuroyanagi G; Yamamoto N; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Mol Med Rep; 2016 Apr; 13(4):3363-9. PubMed ID: 26935864
[TBL] [Abstract][Full Text] [Related]
18. HSP90 inhibitors potentiate PGF2α-induced IL-6 synthesis via p38 MAP kinase in osteoblasts.
Fujita K; Tokuda H; Kuroyanagi G; Yamamoto N; Kainuma S; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
PLoS One; 2017; 12(5):e0177878. PubMed ID: 28542188
[TBL] [Abstract][Full Text] [Related]
19. Involvement of stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK) in prostaglandin F2alpha-induced heat shock protein 27 in osteoblasts.
Tokuda H; Niwa M; Ishisaki A; Nakajima K; Ito H; Kato K; Kozawa O
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):441-7. PubMed ID: 15062846
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol suppresses insulin-like growth factor I-induced osteoblast migration: attenuation of the p44/p42 MAP kinase pathway.
Hioki T; Kawabata T; Sakai G; Fujita K; Kuroyanagi G; Matsushima-Nishiwaki R; Kim W; Otsuka T; Iida H; Tokuda H; Kozawa O
Biosci Biotechnol Biochem; 2020 Dec; 84(12):2428-2439. PubMed ID: 32862787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
